How many employees does Crinetics Pharmaceuticals, Inc. have?

Crinetics Pharmaceuticals, Inc. reported 594 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 35.9% from a year earlier.

What is Crinetics Pharmaceuticals, Inc.'s revenue per employee?

Crinetics Pharmaceuticals, Inc. brought in $7.7M of revenue in fiscal Dec 2025, which is $13K per employee. That ranks 39 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Crinetics Pharmaceuticals, Inc. employees and revenue per employee

CRNX · Biotechnology · $8.99B market cap

Crinetics Pharmaceuticals, Inc. had 594 employees at the end of fiscal Dec 2025, up 35.9% from a year earlier. Revenue for the year was $7.7M, up 640.7% from a year earlier, or $13K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

594

+35.9% YoY

Revenue

$7.7M

+640.7% YoY

Revenue / employee

$13K

Peer median $602K

Rank in industry

39 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2018

Hover a year for the numbers.

CRNX employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	594	$7.7M	$13K	+35.9%	+640.7%
Dec 2024	437	$1.0M	$2K	+50.7%	-74.1%
Dec 2023	290	$4.0M	$14K	+38.1%	-15.3%
Dec 2022	210	$4.7M	$23K	+46.9%	+339.4%
Dec 2021	143	$1.1M	$8K	+53.8%	+1418.3%
Dec 2020	93	$71,000	$1K	+36.8%	-94.0%
Dec 2019	68	$1.2M	$18K	+44.7%	-50.9%
Dec 2018	47	$2.4M	$52K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Crinetics Pharmaceuticals, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
AMLX Amylyx Pharmaceuticals, Inc.	123	$87.4M	$710K	Contracting
PTGX Protagonist Therapeutics, Inc.	132	$46.0M	$349K	Hiring into decline
NUVB Nuvation Bio Inc.	298	$62.9M	$211K	Efficient growth
KYMR Kymera Therapeutics, Inc.	238	$39.2M	$165K	Hiring into decline
RLAY Relay Therapeutics, Inc.	192	$15.4M	$80K	Leaner
PRAX Praxis Precision Medicines, Inc.	116	$8.6M	$74K	Efficient growth
PGEN Precigen, Inc.	160	$9.7M	$61K	Efficient growth
IMNM Immunome, Inc.	177	$6.9M	$39K	Hiring into decline
CRNX Crinetics Pharmaceuticals, Inc.	594	$7.7M	$13K	Efficient growth

Every Healthcare company

Questions about Crinetics Pharmaceuticals, Inc.

How many employees does Crinetics Pharmaceuticals, Inc. have?: Crinetics Pharmaceuticals, Inc. reported 594 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 35.9% from a year earlier.
What is Crinetics Pharmaceuticals, Inc.'s revenue per employee?: Crinetics Pharmaceuticals, Inc. brought in $7.7M of revenue in fiscal Dec 2025, which is $13K per employee. That ranks 39 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare CRNX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Crinetics Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell CRNX.